Aesculin based glucosamine-6-phosphate synthase inhibitors as novel preservatives for food and pharmaceutical products: in-silico studies, antioxidant, antimicrobial and preservative efficacy evaluation
Amit Lather1,
Sunil Sharma2 &
Presently available chemical based synthetic preservative have emerged with various side effects, so the aspiration of natural and side effect free novel preservative has been greatly increased. As the natural preservative exhibit poor side effect with improved preservative efficacy. The recent development in computational studies leads advancement in drug designing and discovery of novel glucosamine-6-phosphate synthase (G-6-P synthase) inhibition based natural antimicrobial preservatives. Here, selected aesculin derivatives were screened for G-6-P synthase inhibition via docking study and evaluated for antioxidant, antimicrobial, preservative efficacy as well stability study.
Modified aesculin derivatives were designed, synthesized and showed potent G-6-P synthase inhibition with remarkable antimicrobial, antioxidant, preservative efficacy and stability study. The molecular docking with target pdb id 1moq from G-6-P synthase resulted with better dock score and energy for compound 1 as compared to standard drugs streptomycin, ciprofloxacin, ampicillin and fluconazole, that supported the wet lab results. Among the synthesized compounds, the compound 1 possessed good antioxidant activity as compared to standard L-ascorbic acid. The resultant data for antimicrobial activity of aesculin derivatives revealed compound 1 as the most potent antimicrobial compound as compared to the standard drugs streptomycin, ciprofloxacin, ampicillin and fluconazole. While compound 2 showed better antimicrobial activity as compared to streptomycin, ciprofloxacin, ampicillin. The preservative efficacy test for compound 1 in aloe vera juice and white lotion USP has been showed the log CFU/mL values within the prescribed limit of USP standard and results were comparable to standard sodium benzoate, ethyl paraben and propyl paraben. Compound 1 has been found to be within prescribed limit of stability study over six month.
Compound 1 showed the potent G-6-P synthase inhibitory, antioxidant, antimicrobial, preservative efficacy and stability study results as compared to standard drugs taken. The results have found comparable to molecular docking results, and this final compound may be used as new preservatives for food and pharmaceutical products. Moreover, the mechanistic insight into the docking poses was also explored by binding interactions of aesculin derivatives inside the pdb id 1moq. These results also supported the results for novel synthesized G-6-P synthase inhibitors.
Glucosamine-6-Phosphate synthase (G-6-P synthase) catalyzed the first step in hexosamine biosynthesis and converted Fructose-6-Phosphate (Fru-6-P) into GlcN-6-P (Glucosamine-6-Phosphate), a precursor of Uridine Diphosphate N-acetyl glucosamine (UDP-NAG). NAG is an essential constituent of the peptidoglycan layer of the microbial cell wall as shown in Fig. 1. Accordingly, G-6-P synthase offers a potential target for the action of antimicrobial agents and hence, it has attracted the interest of several researchers [1].
Role of G-6-P synthase in microbial cell wall synthesis
Moreover, the reported literature revealed for the adverse effects of exiting antimicrobial based preservatives viz. estrogenic effect, contact eczema, endocrine disruption, various types of cancer, etc. Hence, the search of better, and safe preservatives for food, pharmaceutical and cosmetic products seems necessary [2, 3].
The plants contains wide variety of phytoconstituents with diverse structural heterogeneity as compared to synthetic compounds and are also considered as an important source of novel and safe therapeutic agents [4]. The 3D-crystallographic structure of enzyme involved in microbial cell wall synthesis i.e. G-6-P synthase is available and can be explored as a novel target for search of better antimicrobial compounds [5]. Moreover, the phytoconstituents of plants with reported antimicrobial efficacy may be explored using the molecular docking and large number of molecules can be screened within a short time [6]. Further, the docking simulations if combined with synthetic medicinal chemistry to modify the phytoconstituents, it may help to design highly potent G-6-P synthase inhibitors. Several plant based G-6-P synthase inhibitors such as catechin, luteolin, etc. have been reported for their antimicrobial efficacy [7,8,9]. Hence, similar to this there is a scope to explore the other selected phytoconstituents for discovery of safe and better G-6-P synthase inhibitors.
Aesculin, β-d-glucose-6,7-dihydroxy coumarin is a compound derived from the horse chestnut tree has been associated with different biological properties such as anti-oxidant, photo-protective, inhibition of oxidative DNA damage, chemo-preventive, gastro protective, anti-tumor, etc. [10,11,12].
It has also been reported in our previous study that aesculin can act as an active inhibitor of G-6-P synthase enzyme based upon the results of molecular docking and ADMET data [13]. Hence, it was planned to explore various derivatives of aesculin for their antimicrobial, antioxidant, preservative efficacy and stability behavior to compare the wet lab results with that of the results of molecular docking.
Materials and methods used
All the chemicals and reagents used in the experimental part of the study were of analytical grade. Nutrient agar, nutrient broth, sabouraud dextrose agar, and sabouraud broth were purchased from HiMedia Laboratories (Mumbai, India). Aesculin, 2,2-diphenyl-1-picrylhydrazyl (DPPH), anilines, hydrochloric acid were purchased from Sigma Aldrich (Germany), LobaChemie (Mumbai, India), and SRL (Mumbai, India). Reaction progress was checked by thin-layer chromatography (TLC) method. Standard streptomycin, ampicillin, ciprofloxacin, and fluconazole were obtained from Belco Pharma, Bahadurgarh (India). The standard microbial strains E. coli 45, S. aureus 3160, P. aeruginosa 1934, C. albicans 183 and A. niger 282 were obtained in lyophilized form from MTCC, Chandigarh (India). Melting point was recorded by the Sonar melting point apparatus. FTIR spectra were recorded on Perkin Elmer FTIR spectrophotometer, 1H NMR, and 13C NMR spectra were recorded on Bruker Avance II 400 NMR spectrometer. Mass spectra were recorded on Waters Micromass Q-ToF Micro instrument while the elemental analysis was done by Perkin Elmer 2400 elemental analyzer.
The three-dimensional structures of aesculin derivatives were constructed by using Chemdraw ultra 8, and energy was minimized with the LigPrep tool of Schrodinger Maestro. The X-ray crystal structures of G-6-P synthase were downloaded from the Protein Data Bank (http://www.rcsb.org/pdb). PDB ID 1MOQ (resolution of 1.57 Å) was selected on the basis of the lowest resolution as well availability and water molecules (except those coordinated to metals and between the ligand–protein) were removed with the help of Schrodinger protein preparation wizard [14]. The energy-restrained of the protein structure target site optimization of targeted protein G-6-P synthase was done by using Optimized Potential for Liquid Simulations (OPLS-2005) as force field. The partial charges were computed according to the OPLS-2005 force field (32 stereoisomers, tautomers, and ionization) on biological pH. All the calculations were carried out by using Schrodinger, Inc. (New York, USA) software Maestro 11 with an induced fit docking (IFD) method. The ligands prepared after energy minimization was used for molecular docking studies. All the computational work was performed in Laboratory for preservation technology and Enzyme Inhibition Studies, Department of Pharmaceutical Sciences, M.D. University, Rohtak, INDIA, was used for all computational work [15, 16].
ADMET analysis
Quick prop from Schrodinger was utilized for in-silico prediction of ADME properties of proposed and synthesized aesculin derivatives. Various ADME parameters were calculated such as Log P, number of rotatable bonds, number of hydrogen acceptor, Log BB, and number of hydrogen bond donor atoms. Lipinski's rule of five was also used for the prediction of a drug-like profile of newly synthesized derivatives.
Procedure for synthesis of aesculin derivatives
Aesculin derivatives were synthesized by some modifications in the procedure of Yang et al. 2006 as outlined in Fig. 2 [17]. The proposed derivatives were synthesized with substituted aniline (0.01 mol) taken in a round bottom flask. To this reaction mixture, concentrated hydrochloric acid was added dropwise with continuous stirring. Aesculin (0.01 mol) was dissolved in ethanol (50 mL) in equimolar concentration and was refluxed. Synthesis of derivatives was monitored by single spot TLC. On the completion of reaction the concentrated reaction mixture was precipitated. Recrystallization of the crude products was done by using alcohol. The final structure of the compounds was confirmed by FTIR, 1H NMR spectra, 13C NMR spectra, mass spectra and elemental analysis.
Design strategy and Scheme for the synthesis of aesculin derivatives
2-(3,4-dihydroxyphenyl)-3-(3-nitrophenylamino)chroman-5,7-diol (Compound 1)
Rf TLC mobile phase: Methanol: Chloroform (20:80) = 0.56; Yield = 35%; M.P. = 220–222 °C; M.Wt. = 429.14; IR (KBr pellets) cm−1: 1383 (–C–O–C), 1040 (–C–C–), 1684 (–C=N–), 2948 (–C–H–), 3387 (–OH–); 1H NMR (400 MHz, CDCL3): δ 9.93 (s, 1H), 7.66 (d, J = 9.2 Hz, 1H), 7.52 (d, J = 8.5 Hz, 1H), 7.44 (s, 1H), 7.35 (d, J = 6.0 Hz, 2H), 7.30 (d, J = 8.4 Hz, 2H), 7.28 (t, J = 8.0 Hz, 1H), 6.87 (s, 1H), 5.04 (s, 1H), 4.95 (d, J = 8.1 Hz, 1H), 4.62 (d, J = 7.2 Hz, 1H), 4.59 (d, J = 9.7 Hz, 1H), 4.52 (d, J = 10.6 Hz, 1H), 4.13 (d, J = 8.0 Hz, 1H), 4.07 (d, J = 7.8 Hz, 1H), 3.73 (dd, J = 13.8, 7.5 Hz, 1H), 3.50 (q, J = 9.3, 8.8 Hz, 1H), 3.41 (s, 2H), 3.38 (q, J = 8.5 Hz, 1H), 3.25–3.23 (m, 1H); 13C NMR (400 MHz, CDCL3) δ 160.24, 149.30, 147.84, 145.58, 145.08, 137.34, 129.17, 127.71, 126.97, 114.97, 112.87, 111.52, 102.93, 101.32, 79.51, 74.14, 73.41, 54.69, 38.44, 25.96, 12.61, 10.1; MS ES + (ToF): m/z 429.14 [M++2]; CHNS: Calc (C23H23NO8): C, 61.53; H, 5.40; N, 3.26; O, 29.81; Found C, 61.54; H, 5.42; N, 3.27; O, 29.78.
2-(3,4-dihydroxyphenyl)-3-(naphthalen-1-ylamino)chroman-5,7-diol (Compound 2)
Rf TLC mobile phase: Methanol: Chloroform (20:80) = 0.60; Yield = 40%; M.P.; 168–170 °C; M.Wt. = 465.14;; IR (KBr pellets) cm−1: 1166 (–C–O–C), 1077 (–C–C–), 1457 (–C = C–), 1699 (–C=N–), 2936 (–C–H–), 3390 (–OH–); 1H NMR (400 MHz, CDCL3) δ 9.93 (s, 1H), 8.32 (d, J = 7.3 Hz, 1H), 7.95 (d, J = 8.9 Hz, 2H), 7.86 (d, J = 8.4 Hz, 1H), 7.64 (d, J = 8.1 Hz, 1H), 7.56 (d, J = 10.8 Hz, 2H), 7.54 (d, J = 8.1 Hz, 1H), 7.31 (s, 1H), 7.13 (d, J = 8.6 Hz, 1H), 6.75 (s, 1H), 5.04 (s, 1H), 4.95 (d, J = 8.1 Hz, 1H), 4.62 (d, J = 7.6 Hz, 1H), 4.13 (d, J = 8.1 Hz, 1H), 4.07 (d, J = 8.6 Hz, 1H), 3.73 (dd, J = 13.8, 7.5 Hz, 1H), 3.50 (q, J = 8.9 Hz, 1H), 3.41 (s, 2H), 3.38 (q, J = 8.5 Hz, 1H), 3.25–3.23 (m, 1H); 13C NMR (400 MHz, CDCL3) δ 163.20, 149.30, 146.42, 146.35, 145.76, 145.58, 133.27, 129.24, 128.14, 128.06, 126.64, 126.56, 123.70, 122.78, 122.06, 112.87, 111.70, 110.94, 103.36, 101.62, 77.41, 75.43, 73.23, 70.74, 62.21; MS ES + (ToF): m/z 467.16 [M++2]; CHNS: Calc (C25H23NO8): C, 64.51; H, 4.98; N, 3.01; O, 27.50; Found C, 64.53; H, 4.97; N, 3.02; O, 27.47.
In vitro evaluation of antioxidant potential of synthesized derivatives of selected leads using DPPH method
The ability of the synthesized aesculin derivatives to scavenge DPPH radicals was determined by DPPH free radical scavenging method. The aliquot of test compounds at different concentrations in methanol was mixed. The different concentration used for the evaluation antioxidant potential includes 12.5, 25, 50, 75 and 100 μg/mL. The 0.1 mM solution of DPPH was prepared in methyl alcohol, and 1 mL of this solution was further diluted to 3 mL both for the sample and standard. After 30 min of incubation in darkness and at ambient temperature, the resultant absorbance was recorded at 517 nm. The tests were performed in triplicate and the % inhibition of compounds was calculated by using the formula:
$$\% {\text{ Inhibition }} = \, \left( {{\text{A}}_{{\text{c}}} {-}{\text{ A}}_{{\text{s}}} } \right) \, \times { 1}00/{\text{A}}_{{\text{c}}}$$
Here, Ac was the absorbance of the control, and As was the absorbance of the sample [18].
In vitro evaluation of antimicrobial potential of synthesized derivatives of selected leads by using tube dilution method
The newly synthesized aesculin derivatives were further evaluated for their antimicrobial potential against various MTCC strains viz. E. coli 45, P. aeruginosa 1934, S. aureus 3160, P. mirabilis 3310, A. niger 282 and C. albicans by broth dilution method. The highest dilution of the test compound resulting in no growth of microorganism was recorded as their MIC value. Dilutions of test and standard compounds were prepared in double strength nutrient broth I.P. (bacteria) or Sabouraud dextrose broth I.P. (fungi) [19]. A 0.9% NaCl solution was used to adjust the turbidity of bacterial and fungal cultures. The CFU and density of microorganism was adjusted to 0.5 McFarland standards with the help of distilled water [20]. The samples were incubated at 37 °C for 24 h (bacteria), at 37 °C for 7 days (A. niger), and at 37 °C for 48 h (C. albicans), and the results were recorded in pMIC.
Evaluation of preservative efficacy of selected antimicrobial/antioxidant derivatives
White lotion USP and Aloe vera juice was used for evaluation of preservative efficacy of the selected aesculin derivatives. Selected derivatives of aesculin were used as preservatives in equivalent amount in cosmetic and the food product [21]. Aloe vera juice was prepared as per the method described by Ahlawat et al. with slight modifications. The aloe vera juice thus obtained was used for the testing of food preservative efficacy [22, 23]. White lotion USP was prepared as per the method of Narang et al. The compounds 1 and 2 in equimolar amount (0.0013 mol of methyl paraben) were used as novel preservatives by replacing standard preservatives sodium benzoate, methyl paraben and propyl paraben in both the preparations [24]. Standard strains of P. aeruginosa 1934, S. aureus 3160, E. coli 45, A. niger 282, and C. albicans 183 from MTCC were used as common microbial contaminants for evaluation of a preservative efficacy as per the protocol described in I.P., 2010 [25].
Test procedure
Aloe vera juice and White lotion USP were taken for preservative efficacy study and compound 1 was added as test preservative in equimolar quantity (0.0013 mol of methyl paraben) to that of standard preservative. A microbial cell count of 1 × 105–1 × 106 cfu/mL was used for microbial inoculation in a quantity of 0.5–1% to the volume of the product taken for study. Samples were incubated at room temperature for 28 days. On incubation the CFU/mL of the product was determined at 0 day, 7 days, 14 days, 21 days, and 28 days by using agar pour plate technique [26]. As per the USP standard protocol the log values of cfu/mL was calculated as not less than 2.0 log reduction from initial count at 14th day of incubation and no increase in microbial count from 14th day to 28th days for fungi [27].
Stability study of the selected preservatives as per ICH guidelines
From the results of preservative efficacy study, compound 1 was selected for further evaluation of its stability behavior as per the ICH guidelines. The compound 1 was added in the final containers containing the preparations of Aloe vera juice and White Lotion USP. Both the preparations having standard preservative and the test compound 1 were stored at 40° ± 2 °C at 75% RH ± 5% RH (as per ICH guidelines) and were analyzed for the change in pH and cfu/ml at the time interval of 0, 1, 2, 3, 4, 5 and 6 months.
All the data was represented as mean ± standard deviation (SD) for three triplicates of each sample. One-way ANOVA test at a significance level of 0.05 (p < 0.05) using MS excel statistical tool was used to analyze the experimental data.
Docking study
The molecular docking of the proposed aesculin derivatives with the target site of pdb id 1moq showed that all the inhibitors were exhibiting better binding with different amino acids in active pocket of the enzyme G-6-P synthase. Binding pattern of compound 1 and 2 with G-6-P synthase has been shown in Fig. 3.
Binding pattern of compound 1 and 2 with G-6-P synthase
The compound 1 and compound 2 were selected as the most active compounds based upon the dock score, binding energy, and ADMET parameters. Compound 1 exhibited better dock score (− 10.972) and binding energy (− 68.466 kJ/mol) values as compared to the dock scores (− 5.18, − 5.06, − 5.12) and binding energies (-37.16 kJ/mol, − 25.41 kJ/mol and − 23.15 kJ/mol) of standard drugs ciprofloxacin, ampicillin, and fluconazole respectively. Similar results were also reported for compound 2 as well and molecular docking results of different ligands within the binding pocket of enzyme G-6-P synthase environment have been shown in Table 1 [28].
Table 1 Docking score, binding energy showed by aesculin derivatives in comparison to standard antimicrobials
The aesculin derivatives exhibited a suitable drug-like profile and the evaluation of different ADMET parameters have been represented in Table 2. Aesculin derivatives showed the value of various descriptors like rotatable bonds should be ≤ 10, QPlogBB should be > 1.0, and QPPCaco cell permeability should be in a range from 4 to 70 [29,30,31].
Table 2 Different ADMET parameters of aesculin derivatives
Figure 2 with slight modifications was used for the synthesis of aesculin derivatives. With reference to FTIR data formation of compound 1 and 2 was confirmed by peak shifted and also confirmed by the 13C spectra. The change in chemical shift value, coupling constant and multiplicities were analyzed by 1HNMR protons signals of synthesized compounds. Mass spectra were also analyzed for the final confirmation of the synthesized compounds. Elemental analysis also confirmed the synthesis of aesculin derivatives where the percentages of C, H and N in synthesized compounds 1–2 was observed within defined limits. The FTIR, 1H NMR, 13C NMR, mass spectroscopy, and elemental analysis data confirmed the chemical structures of synthesized aesculin derivatives (Additional file 1).
Antioxidant potential
The DPPH free radical scavenging assay confirmed that compound 1 possessed good antioxidant activity with inhibitory concentration IC50 6.531 ± 0.042 µM as compared to standard L-ascorbic acid IC50 value, 8.110 ± 0.069 µM. The results of compounds 2 indicated a moderate antioxidant activity with IC50 7.513 ± 0.076 µM while the aesculin itself has antioxidant potential with IC50 7.513 ± 0.076 µM.
Antimicrobial potential
The resultant data for antimicrobial activity of above mentioned aesculin derivatives revealed compound 1 as the most potent antimicrobial compound (pMIC values 1.53, 1.23, 1.23 and 2.13 µM/mL for P. mirabilis, S. aureus and E. coli respectively) as compared to the standard drugs streptomycin (pMIC values 1.06, 1.06 and 1.96 µM/mL for P. mirabilis, S. aureus and E. coli respectively), ciprofloxacin (pMIC values 1.12, 1.12 and 1.42 µM/mL for P. mirabilis, S. aureus and E. coli respectively), ampicillin (pMIC values 1.14, 0.84 and 1.74 µM/mL for P. mirabilis, S. aureus and E. coli respectively) and fluconazole (pMIC values 1.83 and 1.53 µM/mL for C. albicans and A. niger respectively). While compound 2 showed better antimicrobial activity (pMIC values 1.26, 1.26, 1.57 and 1.57 µM/mL for P. mirabilis, P. aeruginosa, S. aureus and E. coli respectively) as compared to streptomycin (pMIC values 1.06 and 1.06 µM/mL for P. mirabilis and S. aureus respectively), ciprofloxacin (pMIC values 1.42 and 1.42 µM/mL for P. mirabilis and S. aureus respectively), ampicillin (pMIC values 1.14, 0.84 and 0.84 µM/mL for P. mirabilis, P. aeruginosa and S. aureus respectively). Result of antimicrobial activity of aesculin derivatives (pMIC values) has been presented in Table 3. The result of antimicrobial activity revealed that the synthesized compounds have antimicrobial potential as compared to standards drugs. The probable mechanism of antimicrobial activity of aesculin derivatives may be due to the better inhibition of G-6-P synthase.
Table 3 Result of antimicrobial activity of aesculin derivatives (pMIC values)
Preservative efficacy
Preservative efficacy study of the Aloe vera juice and White lotion USP were completed in triplicate and the results were reported as mean ± standard deviation. The result of log CFU/ml for compound 1 revealed that the values were within the prescribed limit as per USP criteria. The selected compound 1 reduced the growth of microbes on the 14th day from the initial count and found to be effective on the 28th day, and results were also comparable to sodium benzoate (Figs. 4, 5). Preservative efficacy study results of compound 1 in Aloe vera juice and White lotion USP has been presented in Table 4.
Preservative efficacy results of compound 1 in Aloe vera juice and degree of microbial log reduction
Preservative efficacy results of compound 1 in White Lotion USP and degree of microbial log reduction
Table 4 Log CFU/ml values of the selected compound 1 in Aloe vera juice and White lotion USP
Stability study
The results of six-months continuous stability testing were performed in triplicate and were reported as mean values. The pH of Aloe vera juice and White lotion USP samples were found to be in the range of 5.5–6.0, which indicated the stability of compound 1 as a preservative as compared to that of the standard preservatives sodium benzoate, propyl paraben, and methyl paraben. The results of the antimicrobial study also concluded the no microbial growth in samples containing compound 1 for 6 months period. These results of stability study showed that the products containing acesculin derivatives (compound 1) are stable for 6 months. Results of stability study have been shown in Table 5.
Table 5 Stability studies of compound 1 in aloe vera juice and White Lotion USP for pH
From the results of antimicrobial study, preservative and stability study it can be concluded that the aesculin derivatives could act as G-6-P synthase inhibitors as the results also in correlation with molecular docking study. This correlation between different studies alo help in concluding the mechanism for the inhibition of G-6-P synthase with different visual binding interactions. The aesculin compound 1 showed superior DPPH scavenging potential, antimicrobial, better preservative efficacy results, and also able to prevent the pH changes and microbial CFU count in used food and pharmaceutical formulation. Therefore, the synthesized aesculin derivatives 1 can be used as novel and superior preservatives for food and pharmaceuticals.
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
ADMET:
Absorption, distribution, metabolism, excretion & toxicity
G-6-P Synthase:
Glucosamine-6-phosphate synthase
CYP P450:
Cytochromes P450
OATP1B1:
Solute carrier organic anion transporter family member 1B1
DHEAS:
PPAR:
Peroxisome proliferator-activated receptors
DPPH UDP-N-acetyl:
2,2-Diphenyl-1-picrylhydrazyl
Glucosamine:
Uridine diphosphate N-acetylglucosamine
UDP-GlcNAc:
UDP-N-acetyl glucosamine
Fru-6-P:
d-Fructose-6-phosphate
GlcN-6-P:
d-Glucosamine-6-phosphate
UDP-NAG:
Uridine Diphospho-N-acetyl Glucosamine
FTIR:
Fourier-transform infrared spectroscopy
IC50:
Inhibitory concentration
MIC:
Minimum inhibitory concentrations
CFU:
Colony forming unit
HBA:
HBD:
MTCC:
Microbial Type Culture Collection
DMSO:
BOD:
Biological oxygen demand
PDB ID:
Protein Data Bank Identification
OPLS:
Optimized potential for liquid simulations
QS:
Quantity sufficient
Bearne SL, Blouin C. Inhibition of Escherichia coli GlcN-6-P synthase by, reactive intermediate analogues, the role of the 2-amino function in catalysis. J Biol Chem. 2002;75(1):135–40.
Darbre PD, Harvey PW. Paraben esters: review of recent studies of endocrine toxicity, absorption, esterase and human exposure, and discussion of potential human health risks. J Appl Toxicol. 2008;28(5):561–78.
Tavares RS, Martins FC, Oliveira PJ, Ramalho-Santos J, Peixoto FP. Parabens in male infertility-is there a mitochondrial connection. Reprod Toxicol. 2009;27(1):1–7.
Koehn FE, Carter GT. The evolving role of natural products in drug discovery. Nat Rev Drug Dis. 2005;4(3):206–29.
Dhiman P, Malik N, Khatkar A. Docking related survey on natural product based new monoamine oxidase inhibitors and their therapeutic potential. CCHTS. 2017;20(6):474–91.
Kitchen DB, Decornez H, Furr JR, Bajorath J. Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Dis. 2004;3(11):935–7.
Krishna PKV, Harish BGV, Kumar SSR, Kumar GK. Antibacterial activity of leaf extract of Delonix elata and molecular docking studies of luteolin. J Biochem Technol. 2012;3(5):S193–7.
Fikrika H, Ambarsari L, Sumaryada T. Molecular docking studies of catechin and its derivatives as anti-bacterial inhibitor for GlcN-6-P synthase. Earth Environ Sci. 2016;31:12009.
Deepa M, Devi PR, Alam A. In silico antimicrobial activity of active phyto compounds from the leaf extract of Vitex negundo linn. against glucosamine-6-phasphate synthase. World J Pharma Pharmaceut Sci. 2016;5(1):1144–56.
Govori S, Haziri A, Ademi K, Neziraj N. Molecular docking studies of fused coumarin derivatives as inhibitors of GlcN-6. J Environ Sci Health Part A. 2017;2:1–5.
Li W, Wang Y, Wang X, Zhang H, He Z, Zhi W, Liu F, Niu X. Gastro protective effect of esculin on ethanol induced gastric lesion in mice. Fundamental Clin Pharmacol. 2017;31(2):174–84.
Kaneko T, Tahara S, Takabayashi F, Harada N. Suppression of 8-oxo-2'deoxyguanosine formation and carcinogenesis induced by N-nitrosobis (2-oxopropyl)amine in hamsters by esculetin and esculin. Free Radic Res. 2004;38:839–46.
Lather A, Sharma S, Khatkar A. Virtual screening of novel glucosamine-6-phosphate synthase inhibitors. CCHTS. 2018;21(3):1–12.
Teplyakov A, Obmolova G, Badet-Denisot MA, Badet B, Polikarpov I. Involvement of the C terminus in intramolecular nitrogen channeling in glucosamine 6-phosphate synthase: evidence from a 1.6 Å crystal structure of the isomerase domain. Structure. 1998;6(8):1047–55.
Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK, Shaw DE. Glide: a new approach for rapid, accurate docking and scoring. Method and assessment of docking accuracy. J Med Chem. 2004;47(7):1739–49.
Godschalk F, Genheden S, Soderhjelm P, Ryde U. Comparison of MM/GBSA calculations based on explicit and implicit solvent simulations. Phy Chem. 2013;15(20):7731–9.
Yangn Z, Sun P. Campare of three ways of synthesis of simple Schiff base. Molbank: M514; 2006
Blois MS. Antioxidant determinations by the use of a stable free radical. Nature. 1958;181(4617):1199–200.
Indian Pharmacopoeia Vol-I. Indian Pharmacopoeia Commission. New Delhi: The Controller of Publications; 2007. p. 37.
Andrews JM. Determination of minimum inhibitory concentration. J Antimicrobiol Chem. 2001;48(S1):5–16.
Maughan RG, Poore RA, Phan BV. Product and procedure for stabilizing Aloe vera gel, US Patent: 0211182A1; 2006
Talib MI, Wayal RR, Parate VR. Development of Aloe vera based ready to serve soft drink. Int Conference on Global Trends in Eng Tech Mgt. 2016;87:216–33.
Ahlawat KS, Khatkar BS. Processing, food applications and safety of aloe vera products: a review. J Food Sci Technol. 2011;48(5):525–33.
Narang R, Narasimhan B, Judge V, Ohlan S, Ohlan R. Evaluaton of preservative effectiveness in an official antacid preparaton. Acta Pharmaceutica Sciencia. 2009;51(3):2259.
Indian Pharmacopoeia. Indian Pharmacopoeia Commission, Ghaziabad, India; 2010, p 27–8
Khatkar A, Nanda A, Kumar P, Narasimhan B. Synthesis, antimicrobial evaluation and QSAR studies of p-coumaric acid derivatives. Arabian J Chem. 2017;10(2):S3804–15.
The United States Pharmacopoeia. Antimicrobial effectiveness testing. Rockville: United States Pharmacopoeial Conventon Inc; 2004.
Wojciechowski M, Milewski S, Mazerski J, Borowski E. GlcN-6-P synthase, a novel target for antifungal agents. Molecular modelling studies in drug design. Acta Biochimica Polonica. 2005;52(3):647–53.
Hopkins AL, Groom CR. The drug gable genome. Nat Revol Drug Dis. 2002;1:727–33.
Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem. 2002;45(12):2615–23.
Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, Sanschagrin PC, Mainz DT. Glide: a new approach for rapid, accurate docking and scoring. Method and assessment of docking accuracy. J Med Chem. 2004;47(7):1739–49.
The authors are highly thankful to the Head, Department of Pharmaceutical Sciences, M.D. University, Rohtak, INDIA for providing essential facilities to accomplished this research.
Laboratory for Preservation Technology, and Enzyme Inhibition Studies, Faculty of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, Haryana, India
Amit Lather & Anurag Khatkar
Department of Pharmaceutical Sciences, G.J.U.S.&T., Hisar, India
Sunil Sharma
Amit Lather
The authors AL, SS and AK have designed, synthesized and carried out the work in equal contribution. All authors read and approved the final manuscript.
The Authors hereby consents to publication of the Work in BMC Chemistry Journal.
Spectral Data File 1.
Lather, A., Sharma, S. & Khatkar, A. Aesculin based glucosamine-6-phosphate synthase inhibitors as novel preservatives for food and pharmaceutical products: in-silico studies, antioxidant, antimicrobial and preservative efficacy evaluation. BMC Chemistry 15, 45 (2021). https://doi.org/10.1186/s13065-021-00769-8
Aesculin
G-6-P synthase
Preservative